Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Bioequivalence Study of Amphotericin B Liposome for Injection

NCT06977490 is registered in ClinicalTrials.gov with Sichuan Huiyu Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT06977490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06977490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Bioequivalence Study of Amphotericin B Liposome for Injection
Lead sponsor
Sichuan Huiyu Pharmaceutical Co., Ltd
Phase
Not applicable
Overall status
Completed
Start date
May 13, 2025
Completion date
October 7, 2025
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

invasive fungal infections, neutropenic fever, visceral leishmaniasis